BMS-962212 is a novel, reversible, direct, and selective inhibitor of factor XIa (FXIa). It is well tolerated, with fast onset of pharmacodynamic (PD) responses and rapid elimination. BMS-962212 increases exposure dependently in activated partial thromboplastin time, and decreases exposure dependently in FXI clotting activity.

纯度：≥98%

CAS：1430114-34-3